CDH2 and sarcoma: We selected CCND1, MTA1, STEAP1, CDH2, CDH11, and CDT2 genes that are known to be involved in metastatic spread in several sarcoma subtypes, and their abnormal expression in tumors correlates specifically with poor prognosis in ES patients [43–46].